Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00478634
Status:
COMPLETED
Last Update Posted:
2012-11-02
First Post:
2007-05-24
Brief Title:
A Phase 1 Study Investigating the Combination of RAD001 Cetuximab and Irinotecan as Second-line Therapy After FOLFOX or XELOX Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
Sponsor:
Organization:
Novartis